Receptor-targeted liposome-peptide-siRNA nanoparticles represent an efficient delivery system for MRTF silencing in conjunctival fibrosis

Scientific Reports
Cynthia Yu-Wai-ManPeng T Khaw

Abstract

There is increasing evidence that the Myocardin-related transcription factor/Serum response factor (MRTF/SRF) pathway plays a key role in fibroblast activation and that knocking down MRTF can lead to reduced scarring and fibrosis. Here, we have developed a receptor-targeted liposome-peptide-siRNA nanoparticle as a non-viral delivery system for MRTF-B siRNA in conjunctival fibrosis. Using 50 nM siRNA, the MRTF-B gene was efficiently silenced by 76% and 72% with LYR and LER nanoparticles, respectively. The silencing efficiency was low when non-targeting peptides or siRNA alone or liposome-siRNA alone were used. LYR and LER nanoparticles also showed higher silencing efficiency than PEGylated LYR-P and LER-P nanoparticles. The nanoparticles were not cytotoxic using different liposomes, targeting peptides, and 50 nM siRNA. Three-dimensional fibroblast-populated collagen matrices were also used as a functional assay to measure contraction in vitro, and showed that MRTF-B LYR nanoparticles completely blocked matrix contraction after a single transfection treatment. In conclusion, this is the first study to develop and show that receptor-targeted liposome-peptide-siRNA nanoparticles represent an efficient and safe non-viral siRNA deliv...Continue Reading

References

Jan 1, 1994·The British Journal of Ophthalmology·L LaniganP T Khaw
Aug 25, 2001·The British Journal of Ophthalmology·D Yorston, P T Khaw
Feb 26, 2003·Investigative Ophthalmology & Visual Science·Tina T L WongPeng T Khaw
Feb 26, 2003·Investigative Ophthalmology & Visual Science·Julie T DanielsPeng T Khaw
May 20, 2003·Nature Biotechnology·Aimee L JacksonPeter S Linsley
Feb 11, 2004·Proceedings of the National Academy of Sciences of the United States of America·Peter C ScacheriFrancis S Collins
Jun 18, 2005·International Journal of Pharmaceutics·Camilla FogedAnne Sundblad
Sep 18, 2007·Experimental Cell Research·Annegret H Dahlmann-NoorMaryse Bailly
Oct 30, 2007·Small·Yu PanWilli Jahnen-Dechent
Jan 9, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Scott A IrvineStephen L Hart
Apr 5, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Aristides D TagalakisStephen L Hart
Oct 4, 2008·The Journal of Physical Chemistry. B·C CarlsonJ J Schlager
Jan 31, 2009·Nature Reviews. Drug Discovery·Kathryn A WhiteheadDaniel G Anderson
Jul 17, 2009·Advanced Materials·Sulin ZhangSubra Suresh
Jul 6, 2010·Acta Biomaterialia·Fu-Wei HuangRen-Xi Zhuo
Jul 9, 2010·American Journal of Ophthalmology·Peter K KaiserUNKNOWN Sirna-027 Study Investigators
Apr 2, 2011·Lancet·Harry A Quigley
Jun 1, 2011·Biomaterials·Aristides D TagalakisStephen L Hart
Nov 4, 2011·The Journal of Biological Chemistry·Larry L LuchsingerMatthew D Layne
Nov 18, 2011·Nanotoxicology·Sourav BhattacharjeeAntonius T M Marcelis
Jan 24, 2013·Biomacromolecules·Aristides D TagalakisStephen L Hart
Nov 26, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·Aristides D TagalakisStephen L Hart
Dec 20, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Florie BorelChristian Mueller
Jul 16, 2014·Nature Reviews. Genetics·Hao YinDaniel G Anderson

❮ Previous
Next ❯

Citations

Nov 2, 2016·Journal of Drug Targeting·Shalmali Bivalkar-MehlaAshok Chauhan
May 10, 2017·Materials Science & Engineering. C, Materials for Biological Applications·Rituparna AcharyaJui Chakraborty
Oct 14, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Yating SunChenguang Zhou
Mar 28, 2018·Nucleic Acid Therapeutics·Rahul R Nikam, Kiran R Gore
Aug 18, 2018·Advanced Healthcare Materials·Shaheer MaherDusan Losic
Aug 23, 2019·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Ming KongJunli Guo
Jan 8, 2021·Veterinary Ophthalmology·András M KomáromyShin Ae Park
Feb 7, 2021·Experimental Eye Research·Aanchal GuptaCynthia Yu-Wai-Man
Sep 28, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Kritika Nayak, Manju Misra
Jul 3, 2021·International Journal of Molecular Sciences·Maria Zena MirandaAndrás Kapus
Jul 3, 2021·Pharmaceutics·Marcela Coelho Silva RibeiroArmando Silva-Cunha
Aug 29, 2021·Pharmaceutics·Yolanda Diebold, Laura García-Posadas
Feb 11, 2020·Current Stem Cell Research & Therapy·Nanxin LiuGang Fu

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection
transmission electron microscopy
confocal microscopy
dynamic light scattering
PCR

Software Mentioned

Image J
DTS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.